Differences in the intracellular fate of free and polymer-bound doxorubicin.

Differences in the intracellular fate of free and polymer-bound doxorubicin.

Item
http://www.wikidata.org/entity/Q30729281
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsLiberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.Albumin-drug conjugates in the treatment of hepatic disorders.Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin.Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and Imaging.Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.Hydrolysable core crosslinked particle for receptor-mediated pH-sensitive anticancer drug delivery.HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition.Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicin.Synergistic Enhancement of Antitumor Efficacy by PEGylated Multi-walled Carbon Nanotubes Modified with Cell-Penetrating Peptide TAT.Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.Nuclear uptake of ultrasmall gold-doxorubicin conjugates imaged by fluorescence lifetime imaging microscopy (FLIM) and electron microscopy.
P2860

Differences in the intracellular fate of free and polymer-bound doxorubicin.

Item
http://www.wikidata.org/entity/Q30729281
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@ast
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@en
type
label
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@ast
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@en
prefLabel
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@ast
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Differences in the intracellular fate of free and polymer-bound doxorubicin.
@en
P2093
P304
P31
P356
10.1016/S0168-3659(02)00016-0
P407
P433
P478
P50
P577
P698